St Luke's

Spirair Receives FDA Clearance for SeptAlign, the First and Only Minimally Invasive Therapy for Mechanical Correction of Nasal Septal Deviation

Retrieved on: 
Monday, April 8, 2024

This comes on the heels of FDA clearance of the SeptAlign bioabsorbable Implant in August 2023 and represents the final step in completing the FDA clearance process for the SeptAlign System.

Key Points: 
  • This comes on the heels of FDA clearance of the SeptAlign bioabsorbable Implant in August 2023 and represents the final step in completing the FDA clearance process for the SeptAlign System.
  • "Septal deviation is one of the primary contributors to nasal airway obstruction.
  • Physicians can't move septal cartilage with medicines so mechanical correction through surgery has been the best choice for many patients.
  • Following the clearance of the SeptAlign system, Spirair plans to begin a Series B fundraising round and start commercialization.

Mountain America Credit Union Partners with Boise State Athletics to Support St. Luke’s Children’s Hospital

Retrieved on: 
Thursday, March 14, 2024

BOISE, Idaho, March 14, 2024 (GLOBE NEWSWIRE) --  Mountain America Credit Union recently donated $12,500 to St. Luke’s Children’s Hospital. This donation was made possible through the credit union’s ongoing support of athletic programs at Boise State University (BSU).

Key Points: 
  • BOISE, Idaho, March 14, 2024 (GLOBE NEWSWIRE) -- Mountain America Credit Union recently donated $12,500 to St. Luke’s Children’s Hospital .
  • This donation was made possible through the credit union’s ongoing support of athletic programs at Boise State University (BSU).
  • “Community service is integral to our core values, and Mountain America is proud to support St. Luke’s Children’s Hospital,” said Sterling Nielsen, president and chief executive officer at Mountain America Credit Union.
  • “We are truly appreciative for Mountain America Credit Union’s continued support of St. Luke’s!

Hubert Benitez, D.D.S., Ph.D., Named 23rd President of Saint Peter's University

Retrieved on: 
Tuesday, March 26, 2024

JERSEY CITY, N.J., March 26, 2024 /PRNewswire-PRWeb/ -- The Saint Peter's University Board of Trustees today announced the appointment of Hubert Benitez, D.D.S., Ph.D., as the 23rd president of Saint Peter's University. He will begin his appointment on July 1, 2024.

Key Points: 
  • Hubert Benitez, D.D.S., Ph.D., has been appointed as the 23rd president of Saint Peter's University.
  • The Saint Peter's University Board of Trustees unanimously selected Dr. Benitez to succeed Eugene J. Cornacchia, Ph.D., who is retiring in June after 17 years as president.
  • JERSEY CITY, N.J., March 26, 2024 /PRNewswire-PRWeb/ -- The Saint Peter's University Board of Trustees today announced the appointment of Hubert Benitez, D.D.S., Ph.D., as the 23rd president of Saint Peter's University.
  • "I want to thank the Board of Trustees for the distinction of being appointed president of Saint Peter's University.

The Inner Circle acknowledges Amir A. Rasheed as a Distinguished Healthcare Professional

Retrieved on: 
Thursday, March 7, 2024

SUGARLAND, Texas, March 7, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Amir A. Rasheed is acknowledged as a Distinguished Healthcare Professional for his contributions to the fields of Oncology and Hematology.

Key Points: 
  • SUGARLAND, Texas, March 7, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Amir A. Rasheed is acknowledged as a Distinguished Healthcare Professional for his contributions to the fields of Oncology and Hematology.
  • Dr. Rasheed pursued his medical education at Dow Medical College where he earned a medical degree.
  • He then relocated to the United States to complete a residency in internal medicine at the State University of New York Health Science Center at Brooklyn.
  • Known for his compassionate care and clinical excellence, Dr. Rasheed has dedicated his life to delivering the highest standard of quality care to his patients.

Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility

Retrieved on: 
Thursday, November 9, 2023

CENTER VALLEY, Pa., Nov. 9, 2023 /PRNewswire/ -- As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.

Key Points: 
  • CENTER VALLEY, Pa., Nov. 9, 2023 /PRNewswire/ -- As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.
  • The event, "Breathing Life into Lung Cancer Awareness," will look at the current state of lung cancer in the U.S. and highlight the importance of early detection.
  • Olympus and the Lung Association want to help people understand who is at risk for lung cancer, for whom a screening is recommended based on the updated U.S Preventive Services Task Force guidelines and what a screening involves.
  • Dr. Stahlnecker, a paid consultant for Olympus, will also address the importance of lung cancer staging once cancer is diagnosed.

Little Giraffe Foundation Names 2023 NICU Support Grant Recipients

Retrieved on: 
Wednesday, November 1, 2023

CHICAGO, Nov. 1, 2023 /PRNewswire-PRWeb/ -- Little Giraffe Foundation, a registered 501(c)(3) organization dedicated to funding neonatal research and supporting families and premature babies in the NICU, announced the 15 recipients of the foundation's 2023 NICU Support Grants. Since 2011, the Little Giraffe Foundation has delivered hospital bags to more than 26,000 families, provided $139,000 toward 148 separate NICU support grants, and provided more than $300,000 in medical grants to 34 different research initiatives. From direct family contact through the gift bags to the upleveling of research and care the support and medical grants provide—every dollar that goes to the Little Giraffe Foundation goes to ensuring the immediate and future care of NICU patients.

Key Points: 
  • CHICAGO, Nov. 1, 2023 /PRNewswire-PRWeb/ -- Little Giraffe Foundation , a registered 501(c)(3) organization dedicated to funding neonatal research and supporting families and premature babies in the NICU, announced the 15 recipients of the foundation's 2023 NICU Support Grants.
  • Since 2011, the Little Giraffe Foundation has delivered hospital bags to more than 26,000 families, provided $139,000 toward 148 separate NICU support grants, and provided more than $300,000 in medical grants to 34 different research initiatives.
  • Thanks to the incredible generosity of our donors, we've been able to allocate 15 grants towards vital NICU programs," said Amanda Santoro, the co-founder and president of the Little Giraffe Foundation.
  • This year's Little Giraffe Foundation's NICU Support Grant recipients are as follows:
    UPMC Carlisle, Carlisle, Pennsylvania — to receive $1,000 for food for mothers of breast-feeding infants, food for the immediate families of NICU infants, gas vouchers for rural families, and direct transportation vouchers for those who live in Carlisle.

NEW REPORT SHOWS ST. LUKE'S UNIVERSITY HEALTH NETWORK SAVES $1 MILLION PER YEAR WITH ROUNDTRIP

Retrieved on: 
Wednesday, October 11, 2023

PHILADELPHIA, Oct. 11, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency. In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency. The study revealed $1 million savings annually through a 67% reduction in overnight stays due to transportation delays, along with averting the need to hire six additional communication center operators to manage the escalating volume of patient transportation requests.

Key Points: 
  • Roundtrip releases groundbreaking impact study revealing St. Luke's University Health Network achieves $1 million in cost savings per year by implementing its patient transportation software.
  • PHILADELPHIA, Oct. 11, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency.
  • In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency.
  • "Our collaboration with St. Luke's University Health Network is a testament to their dedication to embracing innovation," said Mark Switaj, CEO at Roundtrip.

NEW REPORT SHOWS ST. LUKE'S UNIVERSITY HEALTH NETWORK SAVES $1 MILLION PER YEAR WITH ROUNDTRIP

Retrieved on: 
Wednesday, October 11, 2023

PHILADELPHIA, Oct. 10, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency. In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency. The study revealed $1 million savings annually through a 67% reduction in overnight stays due to transportation delays, along with averting the need to hire six additional communication center operators to manage the escalating volume of patient transportation requests.

Key Points: 
  • Roundtrip releases groundbreaking impact study revealing St. Luke's University Health Network achieves $1 million in cost savings per year by implementing its patient transportation software.
  • PHILADELPHIA, Oct. 10, 2023 /PRNewswire/ -- Roundtrip, a leading transportation software solution for health systems and health plans, has released a groundbreaking impact study showing substantial cost savings through enhanced patient transportation efficiency.
  • In partnership with St. Luke's University Health Network, Roundtrip implemented its software to reduce inpatient length of stay and improve staff members' operational efficiency.
  • "Our collaboration with St. Luke's University Health Network is a testament to their dedication to embracing innovation," said Mark Switaj, CEO at Roundtrip.

Heart Failure start-up, Acorai, embarks on the next vital stage towards regulatory approval

Retrieved on: 
Wednesday, August 16, 2023

Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024.

Key Points: 
  • Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024.
  • Acorai is developing a first-of-its-kind, scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide.
  • Dr. Dar is a cardiologist specializing in heart failure and leads the advanced heart failure, heart transplant, and mechanical circulatory support research programme at Harefield Hospital.
  • We look forward to collaborating with Acorai, whose heart monitor may have the potential to 'change the game' in diagnostics, monitoring, and treatment of patients with heart failure."

Heart Failure start-up, Acorai, embarks on the next vital stage towards regulatory approval

Retrieved on: 
Wednesday, August 16, 2023

Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024.

Key Points: 
  • Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024.
  • Acorai is developing a first-of-its-kind, scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide.
  • Dr. Dar is a cardiologist specializing in heart failure and leads the advanced heart failure, heart transplant, and mechanical circulatory support research programme at Harefield Hospital.
  • We look forward to collaborating with Acorai, whose heart monitor may have the potential to 'change the game' in diagnostics, monitoring, and treatment of patients with heart failure."